Skip to content

Child and Infant Learning Project

Neurobehavioral Correlates of Craniosynostosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00077831
Acronym
CILP
Enrollment
535
Registered
2004-02-16
Start date
2001-09-30
Completion date
2015-06-30
Last updated
2015-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniosynostosis

Brief summary

To learn more about the cognitive and motor development of infants and young children born with a craniofacial defect called craniosynostosis.

Detailed description

In the first phase of this multi-site, 10-year longitudinal study, infants with one of four types of single-suture craniosynostosis were recruited: sagittal, metopic, right unilateral coronal, and left unilateral coronal. A case-matched control group of healthy, normal infants was also followed. This study, which is now in its second phase, is following this same cohort of children at the age of 7 years.

Interventions

BEHAVIORALneurobehavioral development

observational study of infant and child development

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
Seattle Children's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Months to 7 Years
Healthy volunteers
No

Inclusion criteria

Enrollment criteria at Phase 1: * Confirmed diagnosis of single-suture, nonsyndromic craniosynostosis (sagittal, metopic, unilateral coronal, or lambdoid) * Corrective (cranioplastic) surgery not yet performed * Child born at 34 weeks gestation or later * Absence of neurological conditions/significant health problems * 33 months or younger at time of enrollment (male or female). Enrollment criteria at Phase 2: All participants enrolled in phase 1 are invited to participate in phase 2.

Design outcomes

Primary

MeasureTime frame
Neurodevelopment as assessed by the Bayley Scales of Infant Development II1st assessment - post diagnosis, pre surgery. 2nd assessment - Target age 18 months. 3rd assessment - Target age 36 months.

Secondary

MeasureTime frame
Neurodevelopment as assessed by the Wechsler Intelligence Scale for Children Version IVTarget age 7 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026